Core Viewpoint - Boston Scientific (BSX) has been a highly searched stock recently, indicating potential investor interest and market activity [1] Earnings Estimate Revisions - For the current quarter, Boston Scientific is expected to report earnings of $0.72 per share, reflecting a year-over-year increase of +16.1% [5] - The Zacks Consensus Estimate for the current fiscal year is $2.91, indicating a year-over-year change of +15.9%, with a +2.2% revision over the last 30 days [5] - The consensus earnings estimate for the next fiscal year is $3.26, showing a change of +11.8% from the previous year, with a +0.9% revision over the past month [6] - Boston Scientific holds a Zacks Rank 2 (Buy), suggesting a favorable outlook based on recent earnings estimate changes [7] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $4.89 billion, indicating a year-over-year increase of +18.6% [11] - For the current fiscal year, the sales estimate is $19.49 billion, reflecting a change of +16.4%, while the next fiscal year's estimate is $21.55 billion, indicating a +10.6% change [11] Last Reported Results and Surprise History - In the last reported quarter, Boston Scientific achieved revenues of $4.66 billion, a year-over-year increase of +20.9%, and an EPS of $0.75 compared to $0.56 a year ago [12] - The company exceeded the Zacks Consensus Estimate for revenues by +2.31% and for EPS by +11.94% [12] - Boston Scientific has consistently beaten consensus EPS and revenue estimates over the past four quarters [13] Valuation - Boston Scientific is graded D on the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [17] - Valuation metrics such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) are essential for assessing whether the stock is overvalued, fairly valued, or undervalued [15][16] Bottom Line - The information presented suggests that Boston Scientific may outperform the broader market in the near term, supported by its Zacks Rank 2 [18]

Core Viewpoint - Arch Capital Group (ACGL) has been a highly searched stock recently, indicating potential investor interest and market activity [1] Earnings Estimates - Arch Capital is expected to report earnings of $2.34 per share for the current quarter, reflecting a year-over-year decline of 9% [5] - The consensus earnings estimate for the current fiscal year is $7.89, indicating a year-over-year decrease of 15% [5] - For the next fiscal year, the consensus earnings estimate is $9.57, showing a year-over-year increase of 21.2% [6] - Over the last 30 days, the earnings estimates have seen slight changes of -1.8% for the current quarter and -0.1% for the current fiscal year [5][6] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $4.68 billion, representing a year-over-year increase of 18.8% [11] - For the current fiscal year, the revenue estimate is $18.91 billion, indicating a growth of 13.8%, while the next fiscal year is projected at $20.32 billion, reflecting a growth of 7.5% [11] Last Reported Results and Surprise History - In the last reported quarter, Arch Capital achieved revenues of $4.56 billion, a year-over-year increase of 21.3% [12] - The EPS for the same period was $1.54, down from $2.45 a year ago, with a surprise of +12.41% compared to the consensus estimate [12][13] - The company has consistently beaten consensus EPS estimates in the last four quarters and topped revenue estimates three times [13] Valuation - Arch Capital has a Zacks Rank of 3 (Hold), suggesting it may perform in line with the broader market in the near term [7][18] - The Zacks Value Style Score for Arch Capital is graded B, indicating it is trading at a discount compared to its peers [17]

Core Viewpoint - Deere has been gaining attention in the market, with its stock performance outpacing the broader S&P 500 index and the farm equipment industry, raising questions about its future trajectory [2]. Earnings Estimates - Deere is expected to report earnings of $5.68 per share for the current quarter, reflecting a year-over-year decline of -33.4%. The consensus estimate for the current fiscal year is $18.89, indicating a -26.3% change [5][6]. - The consensus earnings estimate for the next fiscal year is $21.17, which represents a +12.1% increase compared to the previous year [6]. Revenue Projections - The consensus sales estimate for the current quarter is $10.65 billion, showing a year-over-year decrease of -21.8%. For the current and next fiscal years, the sales estimates are $38.23 billion and $40.52 billion, indicating changes of -14.6% and +6%, respectively [11]. Recent Performance - In the last reported quarter, Deere's revenues were $6.81 billion, down -35.1% year-over-year, with an EPS of $3.19 compared to $6.23 a year ago. The reported revenues fell short of the Zacks Consensus Estimate of $7.7 billion by -11.51% [12]. - The company has consistently beaten consensus EPS estimates in the last four quarters and has exceeded revenue estimates three times during this period [13]. Valuation Metrics - Deere's valuation metrics suggest it is trading at a premium compared to its peers, receiving a Zacks Value Style Score of D, indicating potential overvaluation [17].

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or ...

Ignore the O'Hare lawsuit. Focus on valuation.A bit of litigation news is boosting share prices for United Airlines (UAL 2.34%) stock this morning.Over the weekend, the Chicago Sun-Times reported American Airlines Group (AAL 4.04%) is suing Chicago's O'Hare Airport (more precisely, the "Chicago Department of Aviation") for "prematurely reorganizing gates," taking away four of American's slots and giving five more slots to United. American argues this breaches its seven-year-old airline use and lease agreeme ...

Sales Growth Expectations - Lucid is expected to experience record absolute sales growth in the coming years, with a current sales base of approximately $800 million [1] - Analysts project revenue to increase by 82% in 2025 and by another 91% in 2026, driven by several anticipated vehicle launches [1] Investment Performance - Long-term investors in Lucid have faced significant losses, with a $1,000 investment at the time of the 2021 IPO now valued at only $62 [3] - Both Lucid and Rivian went public in 2021 at high valuations, but their share prices have since dropped by over 80% [3] Sales vs. Market Expectations - Despite aggressive sales growth, with Lucid's revenue increasing by nearly 350% since going public, share prices have plummeted due to overly optimistic market expectations [5] - The high multiples at which both Lucid and Rivian were priced did not align with their actual growth, leading to a sharp decline in valuations [5] Investment Considerations - After a prolonged correction, Lucid shares may now present an attractive opportunity for new investors [6] - The historical performance of Lucid serves as a reminder that the valuation paid by investors is crucial in determining returns, regardless of the company's growth rate [6]

Core Viewpoint - Novo Nordisk's stock has experienced a decline of -2.2% over the past month, underperforming the Zacks S&P 500 composite's -0.5% change and the Zacks Large Cap Pharmaceuticals industry's -2% loss, raising questions about its near-term performance [1] Earnings Estimate Revisions - The consensus earnings estimate for the current quarter is $0.91 per share, reflecting a year-over-year increase of +9.6%, with a recent change of +2.2% over the last 30 days [4] - For the current fiscal year, the consensus earnings estimate is $3.85, indicating a +17.4% change from the previous year, with a +1.3% change in the last 30 days [4] - The next fiscal year's consensus earnings estimate is $4.71, showing a +22.4% change from the prior year, with a +2.1% change over the past month [5] - Novo Nordisk holds a Zacks Rank 3 (Hold), influenced by recent changes in consensus estimates and other earnings-related factors [6] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $11.33 billion, indicating a year-over-year increase of +19.1% [10] - The sales estimates for the current and next fiscal years are $50.66 billion and $58.15 billion, reflecting changes of +20.3% and +14.8%, respectively [10] Last Reported Results and Surprise History - In the last reported quarter, Novo Nordisk achieved revenues of $12.26 billion, a year-over-year increase of +28.9%, and an EPS of $0.91 compared to $0.71 a year ago [11] - The reported revenues exceeded the Zacks Consensus Estimate of $11.34 billion by +8.11%, and the EPS surprise was +9.64% [11] - Over the last four quarters, Novo Nordisk surpassed consensus EPS estimates twice and revenue estimates twice [12] Valuation - Novo Nordisk is graded B in the Zacks Value Style Score, indicating it is trading at a discount to its peers [16]

Core Viewpoint - Costco has been trending positively in the stock market, outperforming the S&P 500 and the discount retail industry, raising questions about its future stock performance [1] Earnings Estimate Revisions - The current quarter's earnings estimate for Costco is $4.25 per share, reflecting a year-over-year increase of +12.4% with a recent change of +0.5% in the consensus estimate [4] - For the current fiscal year, the consensus earnings estimate is $17.96, indicating a change of +11.5% from the previous year, with a slight change of +0.1% over the last 30 days [4] - The next fiscal year's consensus earnings estimate stands at $19.73, showing a change of +9.9% from the prior year, with no change in the estimate over the past month [5] Revenue Growth Forecast - Costco's consensus sales estimate for the current quarter is $63 billion, representing a year-over-year change of +7.7% [10] - The sales estimates for the current and next fiscal years are $274.3 billion and $292.89 billion, indicating changes of +7.8% and +6.8%, respectively [10] Last Reported Results and Surprise History - In the last reported quarter, Costco achieved revenues of $63.72 billion, a year-over-year increase of +9%, with an EPS of $4.02 compared to $3.71 a year ago [11] - The reported revenues exceeded the Zacks Consensus Estimate of $63.22 billion by +0.79%, while the EPS fell short by -1.71% [11] - Over the last four quarters, Costco surpassed consensus EPS estimates three times and revenue estimates two times [12] Valuation - Costco is graded D in the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [16] - Valuation multiples such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) are essential for assessing whether Costco's stock is overvalued or undervalued [14][15] Bottom Line - The information presented may assist in evaluating the market interest surrounding Costco, with a Zacks Rank of 3 suggesting it may perform in line with the broader market in the near term [17]

Signet (SIG) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this jewelry company have returned +9.3%, compared to the Zacks S&P 500 composite's -0.5% change. During this period, the Zacks Retail - Jewelry industry, which Signet falls in, has lost 2.4%. The key question now is: What could be the stock's future direction?Although media ...

All five look intriguing at current levels.In April, the stock market clawed back some of the losses from the prior few months, which was encouraging.In today's video, I am going to discuss five stocks and ETFs I am taking a look at buying in the month of May, based on valuation and for defensive purposes. One of those stocks is Warren Buffett's Berkshire Hathaway (BRK.A 1.43%) (BRK.B 1.28%), which has been outperforming the S&P 500 index. Buffett and company have raised over $300 billion in cash within the ...